Partial loss of MCU mitigates pathology in vivo across a diverse range of neurodegenerative disease models. (2024)
Attributed to:
TARGETING PARKIN & MITOCHONDRIAL DYNAMICS IN HUNTINGTON'S DISEASE
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.celrep.2024.113681
PubMed Identifier: 38236772
Publication URI: http://europepmc.org/abstract/MED/38236772
Type: Journal Article/Review
Volume: 43
Parent Publication: Cell reports
Issue: 2